Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zimmer/Centerpulse Merger Would Build Minimally-Invasive Surgery Portfolio

This article was originally published in The Gray Sheet

Executive Summary

Centerpulse's allogenic bone concentrate (ABC) would give Zimmer a spine fusion product to compete directly with Medtronic Sofamor Danek's InFuse bone graft/LT-CAGE lumbar tapered fusion device
Advertisement

Related Content

Zimmer Rounds Out Spinal Offerings With Abbott Spine Acquisition
Zimmer’s Endius Purchase Is “Part One” Of Spinal Device Acquisition Plan
Zimmer Integration Effort “Ahead Of Schedule,” Will Cost $79 Mil. In 2004
Zimmer To Rivals: Size, Pipeline Are Crucial In Expanding Orthopedic Market
Zimmer Gains Hedrocel Biomaterial Spinal Application Rights Via Implex
Stryker Spine Looks To Correct Domestic Posture With Scannell Appointment
Zimmer/TSL 6-Month Permacol Trial To Support 2004 Launch
S&N Evaluating Oxinium Knee Loosening; Revised Design, Technique Possible
Centerpulse tempts suitors with BAK Vista
Centerpulse Spine-Tech Broadens Pipeline To Include BMP Alternative
Advertisement
UsernamePublicRestriction

Register

MT018445

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel